Cargando…

Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland

Detalles Bibliográficos
Autores principales: Jayaprakash, Kiran, Glasmacher, Stella A., Pang, Bernard, Beswick, Emily, Mehta, Arpan R., Dakin, Rachel, Newton, Judith, Chandran, Siddharthan, Pal, Suvankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359150/
https://www.ncbi.nlm.nih.gov/pubmed/32447548
http://dx.doi.org/10.1007/s00415-020-09919-9
_version_ 1783558988870189056
author Jayaprakash, Kiran
Glasmacher, Stella A.
Pang, Bernard
Beswick, Emily
Mehta, Arpan R.
Dakin, Rachel
Newton, Judith
Chandran, Siddharthan
Pal, Suvankar
author_facet Jayaprakash, Kiran
Glasmacher, Stella A.
Pang, Bernard
Beswick, Emily
Mehta, Arpan R.
Dakin, Rachel
Newton, Judith
Chandran, Siddharthan
Pal, Suvankar
author_sort Jayaprakash, Kiran
collection PubMed
description
format Online
Article
Text
id pubmed-7359150
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-73591502020-07-16 Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland Jayaprakash, Kiran Glasmacher, Stella A. Pang, Bernard Beswick, Emily Mehta, Arpan R. Dakin, Rachel Newton, Judith Chandran, Siddharthan Pal, Suvankar J Neurol Letter to the Editors Springer Berlin Heidelberg 2020-05-23 2020 /pmc/articles/PMC7359150/ /pubmed/32447548 http://dx.doi.org/10.1007/s00415-020-09919-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editors
Jayaprakash, Kiran
Glasmacher, Stella A.
Pang, Bernard
Beswick, Emily
Mehta, Arpan R.
Dakin, Rachel
Newton, Judith
Chandran, Siddharthan
Pal, Suvankar
Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland
title Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland
title_full Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland
title_fullStr Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland
title_full_unstemmed Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland
title_short Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland
title_sort riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in scotland
topic Letter to the Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359150/
https://www.ncbi.nlm.nih.gov/pubmed/32447548
http://dx.doi.org/10.1007/s00415-020-09919-9
work_keys_str_mv AT jayaprakashkiran riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland
AT glasmacherstellaa riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland
AT pangbernard riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland
AT beswickemily riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland
AT mehtaarpanr riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland
AT dakinrachel riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland
AT newtonjudith riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland
AT chandransiddharthan riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland
AT palsuvankar riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland
AT riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland